Management of Symptomatic Retroorbital Lipomas

Diagnostic Approach

Magnetic Resonance Imaging (MRI) with expert evaluation is the preferred imaging method for assessing retroorbital lipomas and can differentiate between benign lipomas and atypical lipomatous tumors (ALT) in up to 69% of cases 1, 2
In cases of diagnostic uncertainty, a percutaneous core biopsy should be performed to analyze MDM-2 amplification and distinguish between lipomas and ALT/well-differentiated liposarcomas 1, 3
Typical MRI features suggestive of ALT include nodularity, septations, and a relatively larger size 1, 4

Complete en-bloc resection is the standard treatment for symptomatic retroorbital lipomas, with a high success rate and low recurrence risk 1, 3, 5
The operation should be performed by a surgeon specifically trained for the treatment of this disease group 6
Marginal resections as complete en-bloc specimens, even if histopathologically classified as R1, offer excellent rates of long-term local control 1, 2

For older patients or those with significant comorbidities, radiological surveillance may be considered if surgery would be associated with high morbidity 1, 3
For larger tumors or those with unclear margins, adjuvant radiotherapy may occasionally be considered 1, 4

ALT/well-differentiated liposarcomas tend to be larger and deeper, with distinct MRI features 1, 4
The definitive diagnostic test is molecular detection of MDM-2 cell cycle oncogene amplification by fluorescence in-situ hybridization 1, 3

After surgical excision and postoperative wound care, patients can be discharged to primary care 1, 4
Re-referral is only required in cases of clinical suspicion of recurrence 1, 3